Related Experiment Video
Updated: Oct 28, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Predictors of family impact of juvenile localized scleroderma
Katia Milovanova1, Merna Adly2, Brendan C Lethebe2
1Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Insights
Juvenile localized scleroderma (jLS) moderately impacts family quality of life. Patient
Area of Science:
- Pediatric Rheumatology
- Dermatology
- Health Outcomes Research
Background:
- Juvenile localized scleroderma (jLS) is a chronic autoimmune condition affecting children.
- The impact of jLS on family functioning and quality of life is not fully understood.
- Identifying factors influencing family impact is crucial for developing targeted support.
Purpose of the Study:
- To quantify the effect of jLS on family quality of life.
- To determine predictors of family impact in pediatric jLS patients.
- To inform the creation of resources that improve family well-being in jLS.
Main Methods:
- Retrospective cohort study involving pediatric jLS patients and their families.
- Utilized five validated questionnaires: PedsQL-FIM, PedsQL-Generic, PedsQL-RM, CHAQ, and CDLQI.
- Linear mixed-effects models analyzed relationships between family impact and clinical variables over time.
Main Results:
- The median baseline family impact score (PedsQL-FIM) was 80.9.
- Patient's general (PedsQL-Generic) and disease-specific (PedsQL-RM) health-related quality of life were significant predictors of family impact.
- Methotrexate use showed a trend toward increased family impact; jLS subtype also influenced outcomes.
Conclusions:
- jLS exerts a moderate but significant impact on family quality of life.
- Patient's overall health status and specific jLS characteristics are key predictors of family burden.
- Family-centered care approaches are essential for managing jLS and supporting affected families.
Objective:
To measure the impact juvenile localized scleroderma (jLS) has on family quality of life and to identify predictors of family impact in this population which may inform the development of tailored resources to enhance family functioning for patients with jLS.
Methods:
A retrospective cohort study of pediatric patients with jLS and their families was conducted. Five questionnaires were administered at each visit: Pediatric Quality of Life Inventory Family Impact Module (PedsQL-FIM), PedsQL 4.0 Generic Core Scales (PedsQL-Generic), PedsQL Rheumatology Module (PedsQL-RM), Child Health Assessment Questionnaire (CHAQ), and Children's Dermatology Life Quality Index (CDLQI). Linear mixed models with random intercepts for each patient were used to find relationships between family impact scores and clinically relevant variables over time. Variables of interest included disease activity status, methotrexate use, jLS distribution, and scores for PedsQL-Generic and PedsQL-RM.
Results:
The median baseline PedsQL-FIM total score was 80.9 (IQR = 76.6-97.4). Adjusting for age and sex, the most significant predictors of family impact were PedsQL-Generic scores and four of five PedsQL-RM dimensions (all P < .001); methotrexate use had borderline significance (P = .06). Family impact increased more significantly over time in older patients. In multivariable modeling, PedsQL-Generic total score and jLS "other" distribution were significant for predicting an increased PedsQL-FIM score (P = .003 and P = .03, respectively).
Conclusions:
JLS has a moderate family impact. Family impact is predicted by patients' general and disease-specific health-related quality of life (HRQL) and their jLS subtype. There is a trend toward increased family impact with methotrexate treatment. This study emphasizes the importance of family-centered care in jLS.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
The JAK-STAT Signaling Pathway
